Review Article Volume 17 Issue 10 - 2025

Oxidative Stress and Mitochondrial Dysfunction in Neurotoxic Damage

A’aesha Mohammad Mahmoud Qasem1 and Ahed J Alkhatib2,3,4*

1Aljawabreh Trading Est, Jordan

2Retired, Department of Legal Medicine, Toxicology and Forensic Medicine, Jordan University of Science and Technology, Jordan

3Department of Medicine and Critical Care, Department of Philosophy, Academician Secretary of Department of Sociology, International Mariinskaya Academy, Jordan

4Cypress International Institute University, Texas, USA

*Corresponding Author: Ahed J Alkhatib, Retired, Department of Legal Medicine, Toxicology and Forensic Medicine, Jordan University of Science and Technology, Jordan and Department of Medicine and Critical Care, Department of Philosophy, Academician Secretary of Department of Sociology, International Mariinskaya Academy, Jordan and Cypress International Institute University, Texas, USA.
Received: September 12, 2025; Published: October 10, 2025



The breakdown of the body's mitochondria and cells is a big cause of a huge range of illnesses. The brain is very sensitive to damages caused by oxygen that’s in excess, because of many fatty substances or lipids present, as well as limited antioxidant defense mechanism. Enabling there to be too many toxic molecules called ROS, origin a bodily imbalance and therefore have a lot of bad effects on our cell "origin" and DNA as well. As the major energy producers in a cell, mitochondria are both the roots of oxidative stress as well as being themselves affected by it. Exposure to toxins like lead and mercury really messes with our brain cells, it slows down the brains energy reservoir, from function that manufactures enzyme. These changes increase brain damage by reaching dangerous cellular developments and by messing incidents in the system of mailing signals between the brain's connections. There is proof that imparted damage goes from the muscles to the brain itself through a harmful loop. To find new approaches to treatment and identify symptoms, and quote; oxidative stress simultaneously contributes to mitochondrial dysfunction and quote; is something mankind needs. Doctors feel that certain medicine or methods can help protect the human brain to be safe. New focus on helping treatment to live the outside life with a stronger environment so the essence of what is going on don’t die.

 Keywords: Oxidative Stress; Mitochondrial Dysfunction; Neurotoxicity; Reactive Oxygen Species; Neurodegeneration

  1. Singh A., et al. “Oxidative stress: a key modulator in neurodegenerative diseases”. Molecules8 (2019): 1583.
  2. Elizabeth Millichap L., et al. “Targetable pathways for alleviating mitochondrial dysfunction in neurodegeneration of metabolic and non-metabolic diseases”. International Journal of Molecular Sciences 21 (2021): 11444.
  3. Nishimura Y., et al. “Oxidative stress as a common key event in developmental neurotoxicity”. Oxidative Medicine and Cellular Longevity (2021): 6685204.
  4. Gupta P., et al. “Role of inflammation and oxidative stress in chemotherapy-induced neurotoxicity”. Immunologic Research6 (2022): 725-741.
  5. He Z., et al. “NAC antagonizes arsenic-induced neurotoxicity through TMEM179 by inhibiting oxidative stress in Oli-neu cells”. Ecotoxicology and Environmental Safety 223 (2021): 112554.
  6. Ma Y., et al. “The effect of oxidative stress-induced autophagy by cadmium exposure in kidney, liver, and bone damage, and neurotoxicity”. International Journal of Molecular Sciences21 (2022): 13491.
  7. Milatovic D., et al. “Neuroinflammation and oxidative injury in developmental neurotoxicity”. In Reproductive and developmental toxicology (2022): 1129-1140.
  8. Ucar A., et al. “Magnetic nanoparticles-induced neurotoxicity and oxidative stress in brain of rainbow trout: Mitigation by ulexite through modulation of antioxidant, anti-inflammatory, and antiapoptotic activities”. Science of the Total Environment 838 (2022): 155718.
  9. Kıran TR., et al. “Oxidative stress and antioxidants in health and disease”. Journal of Laboratory Medicine1 (2023).
  10. Zahra KF., et al. “The involvement of the oxidative stress status in cancer pathology: A double view on the role of the antioxidants”. Oxidative Medicine and Cellular Longevity (2021): 9965916.
  11. Remigante A and Morabito R. “Cellular and molecular mechanisms in oxidative stress-related diseases”. International Journal of Molecular Sciences14 (2022): 8017.
  12. Ramos-González EJ., et al. “Relationship between inflammation and oxidative stress and its effect on multiple sclerosis”. Neurologia3 (2024): 292-301.
  13. Guo C., et al. “Oxidative stress, mitochondrial damage and neurodegenerative diseases”. Neural Regeneration Research 21 (2013): 2003-2014.
  14. Zong Y., et al. “Mitochondrial dysfunction: mechanisms and advances in therapy”. Signal Transduction and Targeted Therapy 1 (2024): 124.
  15. Chen X., et al. “Mitochondrial dysfunction: roles in skeletal muscle atrophy”. Journal of Translational Medicine1 (2023): 503.
  16. Jurcau A. “Insights into the pathogenesis of neurodegenerative diseases: Focus on mitochondrial dysfunction and oxidative stress”. International Journal of Molecular Sciences 21 (2021): 11847.
  17. D'Ascenzo M and Colussi C. “Oxidative stress and the central nervous system”. Antioxidants 1 (2025): 110.
  18. Jomova K., et al. “Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging”. Archives of Toxicology10 (2023): 2499-2574.
  19. Ruczaj A and Brzóska MM. “Environmental exposure of the general population to cadmium as a risk factor of the damage to the nervous system: A critical review of current data”. Journal of Applied Toxicology1 (2023): 66-88.
  20. Verma M., et al. “Excitotoxicity, calcium and mitochondria: a triad in synaptic neurodegeneration”. Translational Neurodegeneration 11 (2022): 3.
  21. Shah N., et al. “Mitochondria: Key mediator for environmental toxicant-induced neurodegeneration”. International Journal of Toxicology 8 (2025): 10915818251369414.
  22. Zuo M., et al. “Mitochondrial dysfunction in environmental toxicology: mechanisms, impacts, and health implications”. Chemical Research in Toxicology11 (2024): 1794-1806.
  23. Zhang Y and Wong HS. “Are mitochondria the main contributor of reactive oxygen species in cells?”. Journal of Experimental Biology5 (2021): jeb221606.
  24. Hernansanz-Agustín P and Enríquez JA. “Generation of reactive oxygen species by mitochondria”. Antioxidants3 (2021): 415.
  25. Napolitano G., et al. “Mitochondrial management of reactive oxygen species”. Antioxidants11 (2021): 1824.
  26. Canton M., et al. “Reactive oxygen species in macrophages: sources and targets”. Frontiers in Immunology 12 (2021): 734229.
  27. Cheng H., et al. “Mechanisms of metal-induced mitochondrial dysfunction in neurological disorders”. Toxics 6 (2021): 142.
  28. Madireddy S and Madireddy S. “Therapeutic strategies to ameliorate neuronal damage in epilepsy by regulating oxidative stress, mitochondrial dysfunction, and neuroinflammation”. Brain Sciences5 (2023): 784.
  29. Jurcău MC., et al. “The link between oxidative stress, mitochondrial dysfunction and neuroinflammation in the pathophysiology of Alzheimer's disease: therapeutic implications and future perspectives”. Antioxidants11 (2022): 2167.
  30. Kausar S., et al. “The role of mitochondria in reactive oxygen species generation and its implications for neurodegenerative diseases”. Cells12 (2018): 274.
  31. Misrani A., et al. “Mitochondrial dysfunction and oxidative stress in Alzheimer's disease”. Frontiers in Aging Neuroscience 13 (2021): 617588.
  32. Kowalczyk P., et al. “Mitochondrial oxidative stress—a causative factor and therapeutic target in many diseases”. International Journal of Molecular Sciences24 (2021): 13384.
  33. Bustamante-Barrientos FA., et al. “Mitochondrial dysfunction in neurodegenerative disorders: Potential therapeutic application of mitochondrial transfer to central nervous system-residing cells”. Journal of Translational Medicine1 (2023): e00292.
  34. Aycan N., et al. “Comparison of oxidative stress markers in umbilical cord blood of vaginal and cesarean babies”. Irish Journal of Medical Science (2025): 1-7.
  35. Singh A., et al. “Oxidative stress: A key modulator in neurodegenerative diseases”. Molecules8 (2019): 1583.
  36. Pei X., et al. “Food‐origin mycotoxin‐induced neurotoxicity: Intend to break the rules of neuroglia cells”. Oxidative Medicine and Cellular Longevity (2021): 9967334.
  37. De Simone G., et al. “Schizophrenia synaptic pathology and antipsychotic treatment in the framework of oxidative and mitochondrial dysfunction: translational highlights for the clinics and treatment”. Antioxidants 4 (2023): 975.
  38. Tseng HC., et al. “Involvement of antioxidant and prevention of mitochondrial dysfunction, anti-neuroinflammatory effect and anti-apoptotic effect: betaine ameliorates haloperidol-induced orofacial dyskinesia in rats”. Brain Sciences7 (2023): 1064.
  39. Madireddy S and Madireddy S. “Therapeutic interventions to mitigate mitochondrial dysfunction and oxidative stress–induced damage in patients with bipolar disorder”. International Journal of Molecular Sciences3 (2022): 1844.
  40. Dobrek L. “A synopsis of current theories on drug-induced nephrotoxicity”. Life2 (2023): 325.
  41. Argueti-Ostrovsky S., et al. “All roads lead to Rome: different molecular players converge to common toxic pathways in neurodegeneration”. Cells 9 (2021): 2438.
  42. Cunha-Oliveira T., et al. “Mitochondria: a promising convergent target for the treatment of amyotrophic lateral sclerosis”. Cells3 (2024): 248.
  43. Chen B., et al. “Neuroprotective effects of natural compounds on neurotoxin-induced oxidative stress and cell apoptosis”. Nutritional Neuroscience5 (2022): 1078-1099.
  44. Pei X., et al. “Targeting HMGB1 inhibits T-2 toxin-induced neurotoxicity via regulation of oxidative stress, neuroinflammation and neuronal apoptosis”. Food and Chemical Toxicology 151 (2021): 112134.
  45. Lin CH., et al. “Exposure to PM2. 5 induces neurotoxicity, mitochondrial dysfunction, oxidative stress and inflammation in human SH-SY5Y neuronal cells”. Neurotoxicology 88 (2022): 25-35.
  46. Bardelčíková A., et al. “Oxidative stress, inflammation and colorectal cancer: an overview”. Antioxidants 4 (2023): 901.
  47. Woo JH., et al. “Power failure of mitochondria and oxidative stress in neurodegeneration and its computational models”. Antioxidants2 (2021): 229.
  48. Trigo D., et al. “Mitochondria, energy, and metabolism in neuronal health and disease”. FEBS Letters9 (2022): 1095-1110.
  49. Aran KR and Singh S. “Mitochondrial dysfunction and oxidative stress in Alzheimer's disease–A step towards mitochondria based therapeutic strategies”. Aging and Health Research4 (2023): 100169.
  50. Bilge S. “Neurotoxicity, types, clinical manifestations, diagnosis and treatment”. Neurotoxicity: New Advances (2022).
  51. Nabi M and Tabassum N. “Role of environmental toxicants on neurodegenerative disorders”. Frontiers in Toxicology 4 (2022): 837579.
  52. Spencer PS and Lein PJ. “Neurotoxicity” (2024).
  53. Alqahtani T., et al. “Mitochondrial dysfunction and oxidative stress in Alzheimer’s disease, and Parkinson’s disease, Huntington’s disease and amyotrophic lateral sclerosis-an updated review”. Mitochondrion 71 (2023): 83-92.
  54. Deepika Thakur A., et al. “Crosstalk between copper, Alzheimer’s disease, and melatonin”. BioMetals 12 (2025): 1-40.
  55. Sanz AB., et al. “Regulated cell death pathways in kidney disease”. Nature Reviews Nephrology5 (2023): 281-299.
  56. Van Loo G and Bertrand MJM. “Death by TNF: a road to inflammation”. Nature Reviews Immunology5 (2023): 289-303.
  57. Newton K., et al. “Dying cells fan the flames of inflammation”. Science6571 (2021): 1076-1080.
  58. Newton K., et al. “Cell death”. Cell2 (2024): 235-256.
  59. Chandel NS. “Mitochondria”. Cold Spring Harbor Perspectives in Biology3 (2021): a040543.
  60. Casanova A., et al. “Mitochondria: It is all about energy”. Frontiers in Physiology 14 (2023): 1114231.
  61. Perluigi M., et al. “Oxidative damage in neurodegeneration: roles in the pathogenesis and progression of Alzheimer disease”. Physiological Reviews1 (2024): 103-197.
  62. Brand MD and Nicholls DG. “Assessing mitochondrial dysfunction in cells”. Biochemical Journal 2 (2011): 297-312.
  63. Karkhanei B., et al. “Evaluation of oxidative stress level: total antioxidant capacity, total oxidant status and glutathione activity in patients with COVID-19”. New Microbes and New Infections 42 (2021): 100897.
  64. Ahmed AY., et al. “A validated method to assess glutathione peroxidase enzyme activity”. Chemical Papers 75 (2021): 6625-6637.
  65. Evstigneeva SS., et al. “Detection and imaging of bacterial biofilms with glutathione-stabilized gold nanoclusters”. Talanta 264 (2023): 124773.
  66. Ahmad A., et al. “Biomarkers as biomedical bioindicators: approaches and techniques for the detection, analysis, and validation of novel biomarkers of diseases”. Pharmaceutics 6 (2023): 1630.
  67. Kehm R., et al. “Protein oxidation-Formation mechanisms, detection and relevance as biomarkers in human diseases”. Redox Biology 42 (2021): 101901.
  68. Sarhadi VK and Armengol G. “Molecular biomarkers in cancer”. Biomolecules8 (2022): 1021.
  69. Hu J., et al. “Mass spectrometric biosensing: a powerful approach for multiplexed analysis of clinical biomolecules”. ACS Sensors10 (2021): 351703535.
  70. Abdelfattah MA J., et al. “Wearable biosensors for health monitoring: advances in graphene-based technologies”. Nanoscale Horizons8 (2025): 1542-1574.
  71. Gualtieri R J., et al. “Mitochondrial dysfunction and oxidative stress caused by cryopreservation in reproductive cells”. Antioxidants3 (2021): 337.
  72. Catanesi M J., et al. “L-methionine protects against oxidative stress and mitochondrial dysfunction in an in vitro model of Parkinson’s disease”. Antioxidants9 (2021): 1467.
  73. Wang DK J., et al. “Mitochondrial dysfunction in oxidative stress‐mediated intervertebral disc degeneration”. Orthopaedic Surgery8 (2022): 1569-1582.
  74. Liao S J., et al. “The fate of damaged mitochondrial DNA in the cell”. Biochimica et Biophysica Acta (BBA)-Molecular Cell Research5 (2022): 119233.

A’aesha Mohammad Mahmoud and Ahed J Alkhatib. “Oxidative Stress and Mitochondrial Dysfunction in Neurotoxic Damage”. EC Neurology  17.10 (2025): 01-10.